Diabetic Foot Infection: Clinical Trials

37 trials for Diabetic Foot Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 recruiting, 3 unknown, 3 withdrawn. 13 Not applicable, 6 Phase 2, 5 Phase 3, 3 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 7, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 26Completed 3, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 35Completed 4, Recruiting 1
Phase 13Completed 1, Recruiting 1, Withdrawn 1
Phase 42Completed 1, Unknown 1
Early Phase 11Withdrawn 1

Follow Diabetic Foot Infection: new trials by email Literature Review of Diabetic Foot Infection trials Research Report on Diabetic Foot Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers
coordinated primary-care-based MDT-model, Standard Care (in control arm) - Diabetic Foot Disease, Diabetic Foot Infection
Not applicableRecruitingNordsjaellands Hospital802026-08-012026-08-05
Continuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.
Solsius SelfCare - Diabetic Foot Disease, Diabetic Foot Infection
Not applicableRecruitingSolsius602026-03-102026-11-02
Nu-3 Gel for Infected Diabetic Foot Ulcers
5% Nu-3 gel, 10% Nu-3 gel, Placebo - Diabetic Foot Infection
Phase 2Not yet recruitingLakewood-Amedex Inc602025-12-012025-03-06
Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic Foot
Intraosseous Vancomycin, Intravenous Vancomycin - Diabetic Foot Disease, Diabetic Foot Infection
Phase 4CompletedBaşakşehir Çam & Sakura City Hospital402025-08-062026-07-10
Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer
Advanced Antibacterial Wound Dressing, Aquacel Ag+ Extra - Diabetic Foot Ulcer, Diabetic Foot Infection
Not applicableActive not recruitingNanordica Medical OU1362024-10-172026-09-18
Study of Infrared Thermography in Diabetic Foot in Guadeloupe
Diabetic Foot Infection
RecruitingCentre Hospitalier Universitaire de la Guadeloupe1502024-09-272025-06-27
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
Next Day Clinic - Pneumonia, Syncope
Not applicableCompletedUniversity of California, Los Angeles5702024-07-222026-05-18
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
Chronic Wounds, Biofilm Infection
RecruitingUniversity of Pittsburgh4052024-04-022026-03-18
Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection
TP-102, Placebo - Diabetic Foot Infection
Phase 2CompletedTechnophage, SA762023-11-082025-12-22
Diabetes Footcare Companion App for Patients and Carers
Conversational Agent/Chatbot App - Diabetes Mellitus Foot Ulcer, Diabetes Mellitus, Type 2
CompletedNanyang Technological University402023-06-232024-01-19
EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot Ulcers
EPC Silver Wound Gel - Diabetic Foot Ulcer, Non-healing Diabetic Foot Ulcer
Not applicableCompletedExciton Technologies Inc.52022-11-282023-09-22
Antibiotic Therapy in Infections of the Diabetic Foot Syndrome
Data collection in patients with diabetic foot syndrome and infections in the area of the foot - Diabetic Foot Infection
CompletedUniversity Hospital, Basel, Switzerland802022-10-122024-07-03
Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients
Topical Pravibismane, Standard of Care - Diabetic Foot Infection, Diabetic Foot
Phase 2CompletedMicrobion Corporation472022-06-132024-11-04
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
contezolid acefosamil (IV)/contezolid (PO), Linezolid (IV and PO) - Diabetic Foot Infection
Phase 3RecruitingMicuRx8652022-05-032026-10-13
PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers
Usual Care alone, System VULNOFAST® plus / VULNOLIGHT® in addition to Usual Care - Diabetic Foot Infection
Not applicableCompletedL.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.782021-09-142026-11-03
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
TTAX01, Standard care - Diabetic Foot Infection, Non-healing Wound
Phase 3CompletedBioTissue Holdings, Inc1062020-11-202025-04-01
Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers
Control; Standard-of-care management, Only PRP injection, PRP + SVF injection - Diabetic Foot Ulcer, Diabetes Mellitus
Phase 1RecruitingUniversity of the Punjab282020-11-202024-12-31
Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis
Omadacycline - Diabetic Foot Infection
CompletedMethodist Health System422020-11-052026-03-27
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
TTAX01, Standard Care - Diabetic Foot Infection, Non-healing Wound
Phase 3CompletedBioTissue Holdings, Inc2202020-07-012024-06-14
Implementation of Telemedicine for Patient With Lower Extremity Wounds
Telemedicine specialty consultation - Peripheral Arterial Disease, Peripheral Artery Disease
Not applicableCompletedUniversity of California, Davis1162020-03-012025-09-04

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Diabetic Foot (17)  ·  Osteomyelitis (5)  ·  Diabetes Mellitus (4)  ·  Foot Ulcer (3)  ·  Infections (2)  ·  Abscess (1)  ·  Acute Kidney Injury (1)  ·  Arthritis, Infectious (1)  ·  Cellulitis (1)  ·  Central Nervous System Infections (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Foot Deformities (1)  ·  Heart Failure (1)  ·  Leg Ulcer (1)

Broader conditions

Cardiovascular Diseases (18)  ·  Skin and Connective Tissue Diseases (18)  ·  Diabetic Angiopathies (17)  ·  Diabetic Neuropathies (17)  ·  Endocrine System Diseases (17)  ·  Skin Diseases (17)  ·  Skin Ulcer (17)  ·  Vascular Diseases (17)  ·  Diabetes Complications (16)  ·  Leg Ulcer (16)  ·  Foot Ulcer (14)  ·  Diabetes Mellitus (13)  ·  Musculoskeletal Diseases (6)  ·  Bone Diseases (5)  ·  Bone Diseases, Infectious (5)

Interventions

Standard of Care (4)  ·  pexiganan (2)  ·  1,2-ethanedithiol (1)  ·  1-phenyl-3,3-dimethyltriazene (1)  ·  Anti-Infective Agents (1)  ·  Biopsy (1)  ·  Cefazolin (1)  ·  Ceftriaxone (1)  ·  Ciprofloxacin (1)  ·  Cloxacillin (1)  ·  Daptomycin (1)  ·  Data Collection (1)  ·  Debridement (1)  ·  Linezolid (1)  ·  Safety (1)

Sponsors

BioTissue Holdings, Inc (3)  ·  Dipexium Pharmaceuticals, Inc. (2)  ·  Microbion Corporation (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Balgrist University Hospital (1)  ·  Başakşehir Çam & Sakura City Hospital (1)  ·  BioMed Valley Discoveries, Inc (1)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Centre Hospitalier Universitaire de la Guadeloupe (1)  ·  Centre Hospitalier Universitaire de la Réunion (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Exciton Technologies Inc. (1)  ·  Faculdade de Medicina do ABC (1)  ·  Hospices Civils de Lyon (1)  ·  Johns Hopkins University (1)

Countries

United States (14)  ·  France (4)  ·  Canada (3)  ·  Italy (3)  ·  Estonia (2)  ·  Switzerland (2)  ·  Bulgaria (1)  ·  China (1)  ·  Denmark (1)  ·  Georgia (1)  ·  Guadeloupe (1)  ·  India (1)  ·  Latvia (1)  ·  Pakistan (1)  ·  Poland (1)

Top investigators

Michael H. Silverman, MD (2)  ·  Abdul Moosa, PI (1)  ·  Aman Khanna (1)  ·  Ariane Sultan (1)  ·  Azra Mehmood, PhD (1)  ·  Carlo Biz, MD (1)  ·  Chandan K Sen, PhD (1)  ·  Eric Partlow, MD, FRCPC (1)  ·  Herbert Slade, MD (1)  ·  Jean-Philippe Lavigne (1)  ·  Julien Vouillarmet, MD (1)  ·  Liew Hui Ling, MBBS (1)  ·  Matthew Crotty, PharmD (1)

Results publications

PMID 19336809, PMID 21873138, PMID 26160556, PMID 26862179, PMID 27401772, PMID 27919259, PMID 30129109, PMID 30664029, PMID 31008367, PMID 31915048, PMID 32801139, PMID 36781451, PMID 38567778, PMID 39040989, PMID 40342512, PMID 41464652, PMID 42836951

NIH funding

K23HL143178 (1), R01DK125835 (1)